Muramoto Katsuki, Urabe Fumihiko, Sakanaka Keigo, Nakano Juria, Kadena Soshi, Narita Chisato, Suzuki Hirotaka, Murakami Masaya, Tsuzuki Shunsuke, Nakamura Mayo, Shimomura Tatsuya, Kimura Takahiro
Department of Urology, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Tokyo, 105-8471 Japan.
Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan.
Int Cancer Conf J. 2024 Jul 2;13(4):407-411. doi: 10.1007/s13691-024-00699-x. eCollection 2024 Oct.
Renal cell carcinoma (RCC) is known for its potential to metastasize to various sites but metastasis to the area posterior to the seminal vesicles is exceedingly rare. We present the case of a 44 year-old male patient with a history of clear cell RCC (ccRCC) who was found to have suspected metastases to the region posterior to the seminal vesicles and the greater omentum during follow-up after radical nephrectomy. The patient was classified as having a favorable risk according to the International Metastatic RCC Database Consortium criteria. Due to the rarity of this metastasis site, a treatment strategy combining immune-oncology therapy and tyrosine kinase inhibitors (IO-TKI) was initiated. This treatment led to significant reduction of the metastatic lesions, allowing for their complete removal via laparoscopic surgery. Pathologic examination confirmed that the metastatic lesions were consistent with primary ccRCC. No clinical progression was observed 2 months postoperatively. This case highlights the rare occurrence of ccRCC metastasizing posterior to the seminal vesicles and demonstrates the potential effectiveness of combined IO-TKI therapy followed by surgical resection in treating such atypical metastases.
肾细胞癌(RCC)以其转移至各种部位的可能性而闻名,但转移至精囊后方区域极为罕见。我们报告一例44岁男性患者,有透明细胞肾细胞癌(ccRCC)病史,在根治性肾切除术后随访期间,发现其精囊后方区域和大网膜疑似转移。根据国际转移性RCC数据库联盟标准,该患者被归类为低危。由于这种转移部位罕见,启动了免疫肿瘤治疗和酪氨酸激酶抑制剂(IO-TKI)联合治疗策略。这种治疗使转移病灶显著缩小,从而能够通过腹腔镜手术将其完全切除。病理检查证实转移病灶与原发性ccRCC一致。术后2个月未观察到临床进展。该病例突出了ccRCC转移至精囊后方的罕见情况,并证明了IO-TKI联合治疗后手术切除在治疗此类非典型转移中的潜在有效性。